Re-evaluation of the predictive score for 6-month graft survival in living donor liver transplantation in the modern era

Liver Transplantation

Volumn 20, Issue 3, 2014, Pages 323-332

  Yoshizumi, Tomoharu ^a   Ikegami, Toru ^a   Bekki, Yuki ^a   Ninomiya, Mizuki ^a   Uchiyama, Hideaki ^a   Iguchi, Tomohiro ^a   Yamashita, Yo Ichi ^a   Kawanaka, Hirofumi ^a   Shirabe, Ken ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; BODY MASS; EVALUATION STUDY; FEMALE; GRAFT SURVIVAL; HUMAN; LIVER TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; MODEL FOR END STAGE LIVER DISEASE SCORE; PORTOSYSTEMIC ANASTOMOSIS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; RELIABILITY; SURGICAL MORTALITY; SURVIVAL RATE;

ADOLESCENT; ADULT; AGED; BODY MASS INDEX; END STAGE LIVER DISEASE; FEMALE; GRAFT SURVIVAL; HUMANS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84896865535     PISSN: 15276465     EISSN: 15276473     Source Type: Journal    
DOI: 10.1002/lt.23804     Document Type: Article

References (31)

1. Alexopoulos S, Matsuoka L, Cho Y, Thomas E, Sheikh M, Stapfer M, et al. Outcomes after liver transplantation in patients achieving a Model for End-Stage Liver Disease score of 40 or higher. Transplantation 2013; 95: 507-512.
2. Angeli P, Gines P,. Hepatorenal syndrome, MELD score and liver transplantation: an evolving issue with relevant implications for clinical practice. J Hepatol 2012; 57: 1135-1140.
3. Halldorson JB, Bakthavatsalam R, Fix O, Reyes JD, Perkins JD,. D-MELD, a simple predictor of post liver transplant mortality for optimization of donor/recipient matching. Am J Transplant 2009; 9: 318-326.
4. Yoshizumi T, Taketomi A, Uchiyama H, Harada N, Kayashima H, Yamashita Y, et al. Graft size, donor age, and patient status are the indicators of early graft function after living donor liver transplantation. Liver Transpl 2008; 14: 1007-1013.
5. Yoshizumi T, Taketomi A, Soejima Y, Ikegami T, Uchiyama H, Kayashima H, et al. The beneficial role of simultaneous splenectomy in living donor liver transplantation in patients with small-for-size graft. Transpl Int 2008; 21: 833-842.
6. Dahm F, Georgiev P, Clavien PA,. Small-for-size syndrome after partial liver transplantation: definition, mechanisms of disease and clinical implications. Am J Transplant 2005; 5: 2605-2610.
7. Ikegami T, Shirabe K, Yoshizumi T, Aishima S, Taketomi YA, Soejima Y, et al. Primary graft dysfunction after living donor liver transplantation is characterized by delayed functional hyperbilirubinemia. Am J Transplant 2012; 12: 1886-1897.
8. Saidi RF, Jabbour N, Li Y, Shah SA, Bozorgzadeh A,. Is left lobe adult-to-adult living donor liver transplantation ready for widespread use? The US experience (1998-2010). HPB (Oxford) 2012; 14: 455-460.
9. Facciuto M, Contreras-Saldivar A, Singh MK, Rocca JP, Taouli B, Oyfe I, et al. Right hepatectomy for living donation: role of remnant liver volume in predicting hepatic dysfunction and complications. Surgery 2013; 153: 619-626.
10. Shin M, Song S, Kim JM, Kwon CH, Kim SJ, Lee SK, Joh JW,. Donor morbidity including biliary complications in living-donor liver transplantation: single-center analysis of 827 cases. Transplantation 2012; 93: 942-948.
11. Reichman TW, Sandroussi C, Azouz SM, Adcock L, Cattral MS, McGilvray ID, et al. Living donor hepatectomy: the importance of the residual liver volume. Liver Transpl 2011; 17: 1404-1411.
12. Dayangac M, Taner CB, Yaprak O, Demirbas T, Balci D, Duran C, et al. Utilization of elderly donors in living donor liver transplantation: when more is less? Liver Transpl 2011; 17: 548-555.
13. Taketomi A, Kayashima H, Soejima Y, Yoshizumi T, Uchiyama H, Ikegami T, et al. Donor risk in adult-to-adult living donor liver transplantation: impact of left lobe graft. Transplantation 2009; 87: 445-450.
14. Ikegami T, Shirabe K, Yoshiya S, Yoshizumi T, Ninomiya M, Uchiyama H, et al. Bacterial sepsis after living donor liver transplantation: the impact of early enteral nutrition. J Am Coll Surg 2012; 214: 288-295.
15. Yoshizumi T, Shirabe K, Soejima Y, Taketomi A, Yamashita N, Ikegami T, et al. Living donor liver transplantation in patients older than 60 years. Transplantation 2010; 90: 433-437.
16. Taketomi A, Sanefuji K, Soejima Y, Yoshizumi T, Uhciyama H, Ikegami T, et al. Impact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantation. Transplantation 2009; 87: 531-537.
17. Yoshizumi T, Ikegami T, Yoshiya S, Motomura T, Mano Y, Muto J, et al. Impact of tumor size, number of tumors and neutrophil-to-lymphocyte ratio in liver transplantation for recurrent hepatocellular carcinoma. Hepatol Res 2013; 43: 709-716.
18. Yoshizumi T, Shirabe K, Ikegami T, Kayashima H, Yamashita N, Morita K, et al. Impact of human T cell leukemia virus type 1 in living donor liver transplantation. Am J Transplant 2012; 12: 1479-1485.
19. Yoshizumi T, Shirabe K, Taketomi A, Uchiyama H, Harada N, Ijichi H, et al. Risk factors that increase mortality after living donor liver transplantation. Transplantation 2012; 93: 93-98.
20. Urata K, Kawasaki S, Matsunami H, Hashikura Y, Ikegami T, Ishizone S, et al. Calculation of child and adult standard liver volume for liver transplantation. Hepatology 1995; 21: 1317-1321.
21. Kamath PS, Wiesner RH, Malinchoc M, Kremers W, Therneau TM, Kosberg CL, et al. A model to predict survival in patients with end-stage liver disease. Hepatology 2001; 33: 464-470.
22. Neumann UP, Langrehr JM, Kaisers U, Lang M, Schmitz V, Neuhaus P,. Simultaneous splenectomy increases risk for opportunistic pneumonia in patients after liver transplantation. Transpl Int 2002; 15: 226-232.
23. Troisi R, Hesse UJ, Decruyenaere J, Morelli MC, Palazzo U, Pattyn P, et al. Functional, life-threatening disorders and splenectomy following liver transplantation. Clin Transplant 1999; 13: 380-388.
24. Troisi R, Ricciardi S, Smeets P, Petrovic M, Van Maele G, Colle I, et al. Effects of hemi-portocaval shunts for inflow modulation on the outcome of small-for-size grafts in living donor liver transplantation. Am J Transplant 2005; 5: 1397-1404.
25. Yamada T, Tanaka K, Uryuhara K, Ito K, Takada Y, Uemoto S,. Selective hemi-portocaval shunt based on portal vein pressure for small-for-size graft in adult living donor liver transplantation. Am J Transplant 2008; 8: 847-853.
26. Ishizaki Y, Kawasaki S, Sugo H, Yoshimoto J, Fujiwara N, Imamura H,. Left lobe adult-to-adult living donor liver transplantation: should portal inflow modulation be added? Liver Transpl 2012; 18: 305-314.
27. Ikegami T, Shirabe K, Nakagawara H, Yoshizumi T, Toshima T, Soejima Y, et al. Obstructing spontaneous major shunt vessels is mandatory to keep adequate portal inflow in living-donor liver transplantation. Transplantation 2013; 95: 1270-1277.
28. Perez-Protto SE, Quintini C, Reynolds LF, You J, Cywinski JB, Sessler DI, Miller C,. Comparable graft and patient survival in lean and obese liver transplant recipients. Liver Transpl 2013; 19: 907-915.
29. Malik SM, deVera ME, Fontes P, Shaikh O, Ahmad J,. Outcome after liver transplantation for NASH cirrhosis. Am J Transplant 2009; 9: 782-793.
30. Siegel AB, Lim EA, Wang S, Brubaker W, Rodriguez RD, Goyal A, et al. Diabetes, body mass index, and outcomes in hepatocellular carcinoma patients undergoing liver transplantation. Transplantation 2012; 94: 539-543.
31. Klein-Wieringa IR, Andersen SN, Kwekkeboom JC, Giera M, de Lange-Brokaar BJ, van Osch GJ, et al. Adipocytes modulate the phenotype of human macrophages through secreted lipids. J Immunol 2013; 191: 1356-1363.